MML Investors Services LLC increased its position in shares of Cooper Companies Inc (NYSE:COO) by 3.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,046 shares of the medical device company’s stock after acquiring an additional 404 shares during the period. MML Investors Services LLC’s holdings in Cooper Companies were worth $3,721,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the stock. BlackRock Inc. grew its position in Cooper Companies by 1.4% during the 1st quarter. BlackRock Inc. now owns 3,784,211 shares of the medical device company’s stock worth $1,120,769,000 after acquiring an additional 51,482 shares during the last quarter. Geode Capital Management LLC grew its position in Cooper Companies by 9.7% during the 4th quarter. Geode Capital Management LLC now owns 721,796 shares of the medical device company’s stock worth $183,414,000 after acquiring an additional 63,889 shares during the last quarter. Northern Trust Corp grew its position in Cooper Companies by 2.4% during the 1st quarter. Northern Trust Corp now owns 602,699 shares of the medical device company’s stock worth $178,501,000 after acquiring an additional 14,293 shares during the last quarter. WCM Investment Management LLC grew its position in Cooper Companies by 0.6% during the 1st quarter. WCM Investment Management LLC now owns 535,205 shares of the medical device company’s stock worth $158,512,000 after acquiring an additional 3,352 shares during the last quarter. Finally, Champlain Investment Partners LLC grew its position in Cooper Companies by 0.3% during the 1st quarter. Champlain Investment Partners LLC now owns 390,720 shares of the medical device company’s stock worth $115,720,000 after acquiring an additional 1,210 shares during the last quarter. Institutional investors and hedge funds own 96.00% of the company’s stock.

A number of equities research analysts recently weighed in on the company. Raymond James restated a “buy” rating on shares of Cooper Companies in a research report on Monday, August 26th. Wells Fargo & Co lifted their target price on Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Piper Jaffray Companies set a $360.00 target price on Cooper Companies and gave the stock a “buy” rating in a report on Friday, August 30th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 target price on the stock in a report on Friday, June 7th. Finally, ValuEngine downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $326.27.

COO traded down $0.73 during midday trading on Friday, hitting $304.27. 11,600 shares of the company were exchanged, compared to its average volume of 322,884. The firm has a market capitalization of $14.72 billion, a P/E ratio of 26.43, a P/E/G ratio of 2.24 and a beta of 0.93. Cooper Companies Inc has a 1-year low of $228.65 and a 1-year high of $344.32. The firm’s 50 day moving average price is $325.48 and its 200-day moving average price is $308.99. The company has a quick ratio of 0.73, a current ratio of 1.29 and a debt-to-equity ratio of 0.39.

Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, August 29th. The medical device company reported $3.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.16 by $0.07. The firm had revenue of $679.40 million for the quarter, compared to the consensus estimate of $687.60 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the previous year, the business earned $3.00 EPS. On average, sell-side analysts predict that Cooper Companies Inc will post 12.32 earnings per share for the current fiscal year.

In other news, Director Gary S. Petersmeyer sold 355 shares of the business’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $323.92, for a total value of $114,991.60. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Randal Golden sold 1,154 shares of the business’s stock in a transaction dated Wednesday, June 19th. The shares were sold at an average price of $328.16, for a total value of $378,696.64. Following the completion of the transaction, the vice president now directly owns 1,148 shares in the company, valued at $376,727.68. The disclosure for this sale can be found here. Insiders sold a total of 10,041 shares of company stock worth $3,285,697 over the last three months. 1.70% of the stock is owned by company insiders.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Further Reading: Purposes and Functions of the Federal Reserve

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.